Cart
sales@molnova.com
Picrasidine I
CAS No. 100234-59-1
Picrasidine I( —— )
Catalog No. M30839 CAS No. 100234-59-1
Picrasidine I has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1728 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product NamePicrasidine I
-
NoteResearch use only, not for human use.
-
Brief DescriptionPicrasidine I has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors.
-
DescriptionPicrasidine I has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number100234-59-1
-
Formula Weight240.3
-
Molecular FormulaC14H12N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Limocitrin 3,7-diglu...
Limocitrin 3,7-diglucoside is a flavonoid isolated from Sedum sarmentosum.
-
VUT-MK142
VUT-MK142 is a new cardiomyogenic small molecule promoting the differentiation of pre-cardiac mesoderm into cardiomyocytes,which may be useful to differentiate stem cells into cardiomyocytes for cardiac repair.VUT-MK142 was identified as the most promising candidate with respect to cardiomyogenic activity.?
-
Nardosinonediol
Nardosinonediol shows cytotoxic activity against P-388 cells.
